Trial Profile
Clinical Trials Insight: 700012983
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 02 May 2006
Price :
$35
*
At a glance
- Drugs Tapentadol (Primary)
- Indications Acute pain
- Focus Therapeutic Use
- Sponsors Grunenthal; Janssen Research & Development
- 02 May 2006 New trial record.